Categories Earnings, Health Care
Earnings Summary: Highlights of Cardinal Health’s (CAH) Q4 2023 results
Pharmaceuticals distributor Cardinal Health (NYSE: CAH) announced financial results for the fourth quarter of 2023, reporting higher revenues and adjusted profit.
- Revenues increased 13% year-over-year to $53.5 billion in the final three months of fiscal 2023
- Fourth-quarter operating earnings came in at $137 million, sharply higher than the $36 million reported a year earlier
- The company reported a net loss of $64 million or $0.25 per share for Q4, compared to a profit of $138 million or $0.50 per share last year
- On an adjusted basis, it was a profit of $1.55 per share, compared to $1.05 per share in the same quarter of 2022
- The Pharmaceutical segment profit increased 12% to $504 million and Medical segment profit rose to $82 million
- The company generated both operating cash flow and adjusted free cash flow of $2.8 billion in Q4
- The management raised its fiscal 2024 adjusted EPS guidance to the range of $6.50 to $6.75, from $6.45-$6.70
Most Popular
Can General Motors (GM) navigate the tariff challenge ahead?
General Motors' (NYSE: GM) stock tumbled last week after the Trump administration imposed new tariffs on automobile imports, raising concerns about their potential impact on the company’s production as it
What to look for when Delta Air Lines (DAL) reports its Q1 2025 earnings results
Shares of Delta Air Lines (NYSE: DAL) were down over 1% on Monday. The stock has dropped 28% over the past three months. The airline is scheduled to report its
STZ Earnings Preview: Can Constellation Brands leverage growing beer sales?
Constellation Brands, Inc. (NYSE: STZ) has effectively navigated challenges like cautious consumer spending and declining demand for its wine and spirits brands by capitalizing on the sustained growth in the
